Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Buy BPC 157 Peptide 99%+ Pure BPC 157 for Research FDA to Convene Pharmacy Compounding Advisory Committee in July The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York 503A vs. 503B Compounding & FDA Regulations Guide Restore Health Consulting fda warning bpc 157 peptide products New Details 157